Explore
Validate
Learn
Western blot
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN361371 - Provider product page
- Provider
- antibodies-online
- Proper citation
- Antibodies-Online Cat#ABIN361371, RRID:AB_10785960
- Product name
- anti-Vimentin (VIM) antibody
- Antibody type
- Polyclonal
- Antigen
- Other
- Reactivity
- Human, Mouse, Rat
- Host
- Chicken/Avian
- Vial size
- 100 µl
- Storage
- Store at -20°C, stable for 1 year
Submitted references Epithelial-mesenchymal transition increases tumor sensitivity to COX-2 inhibition by apricoxib.
Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer.
Kirane A, Toombs JE, Larsen JE, Ostapoff KT, Meshaw KR, Zaknoen S, Brekken RA, Burrows FJ
Carcinogenesis 2012 Sep;33(9):1639-46
Carcinogenesis 2012 Sep;33(9):1639-46
Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer.
Kirane A, Toombs JE, Ostapoff K, Carbon JG, Zaknoen S, Braunfeld J, Schwarz RE, Burrows FJ, Brekken RA
Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Sep 15;18(18):5031-42
Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Sep 15;18(18):5031-42
No comments: Submit comment
No validations: Submit validation data